Phoenix Biotech Acquisition Corp. presently lacks substantial ongoing operations. The company's primary objective is to execute a strategic business integration, which could involve a merger, equity exchange, asset acquisition, stock purchase, corporate restructuring, or a similar transaction with one or more entities. Specifically, it seeks to identify and acquire a company operating within the healthcare sector or related industries across both the United States and European markets.